查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1427726

2024年生物可吸收医疗材料全球市场报告

Bioresorbable Medical Material Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

生物可吸收医疗材料的市场规模预计在未来几年将显着成长。预计到 2028 年将以 9.7% 的复合年增长率 (CAGR) 增长至 22.4 亿美元。预测期内的预期增长是由对生物可吸收支架的需求增加、生物可吸收材料在各种医疗应用中的广泛采用、使用这些材料的心血管和整形外科手术数量的增加以及患者舒适度推动的。这可归因于几个重要因素，包括更关注实现更快的恢復并扩大组织工程中的应用。预测期内预计的主要趋势包括针对特定医疗应用客製化生物可吸收材料、将生物可吸收材料整合到药物输送系统中以及在生物可吸收医疗设备製造中使用3D列印。成长、以生物可吸收元件为特色的组合产品的开发，并更加重视永续和环保的医疗材料。这些趋势表明生物可吸收医疗材料不断发展以满足多样化的医疗需求，符合医疗保健行业定制、技术进步和永续性的更广泛趋势。我是。

外科手术的快速增加预计将显着推动生物可吸收医疗材料市场的扩张。外科手术涉及切口和特殊工具来治疗体内疾病。生物可吸收聚合物广泛用于模製医疗设备，特别是在神经科、整形外科和美容外科领域。这些材料可用于製造缝线、锚钉和螺丝等产品。例如，英国的报告显示，到 2022 年，英国的经导管主动脉瓣置换术术(TAVR) 或经导管主动脉瓣植入术(TAVI) 手术数量将从2019/20 年的5,670例增加到2020 年。 /21 至 6,328 例。因此，手术数量的增加是生物可吸收医疗材料市场的驱动力。

快速成长的老龄化人口将显着推动生物可吸收医疗材料市场的成长。人口老化是指社会中65岁及以上人口比例不断增加的人口变化。老年人对医疗干预的需求不断增长，加上对先进的生物可吸收解决方案的偏好，以减少后续植入移除手术的需要，正在推动生物可吸收医疗材料市场的扩张。例如，根据加拿大一家专门提供当代趋势视觉内容的公司Visual Capitalist的数据，到2022年，全球65岁及以上的人口总数将总合7.71亿，几乎占世界人口的10%。因此，人口老化的加剧是生物可吸收医疗材料市场成长的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球生物可吸收医用材料市场，按类型、性能和预测细分，2018-2023、2023-2028、2033
  • 聚乳酸（PLA）
  • Polyglycolic乙醇酸 (PGA)
  • 多醣
  • 聚己内酯 (PCL)
  • 聚乳酸-乙醇酸共酸（PLGA）
  • 全球生物可吸收医用材料市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 药物输送
  • 整形外科
  • 其他用途
  • 全球生物可吸收医疗材料市场，依最终用户细分、绩效与预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 门诊手术中心
  • 研究机构
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球生物可吸收医疗材料市场，按地区、绩效及预测，2018-2023年、2023-2028年、2033年
  • 全球生物可吸收医疗材料市场，依国家、绩效及预测，2018-2023年、2023-2028年、2033年

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 生物可吸收医用材料市场竞争形势
  • 生物可吸收医用材料市场公司概况
    • Johnson &Johnson
    • Abbott Laboratories
    • Medtronic PLC
    • Kureha Corporation
    • Evonik Industries AG

第31章 其他大型创新公司

  • Stryker Corporation
  • Toray Industries Inc.
  • Mitsui Chemicals Inc.
  • Arkema SA
  • Royal DSM NV
  • Zimmer Biomet Holdings Inc.
  • COFCO Biotechnology Co. Ltd.
  • Ashland Global Holdings Inc.
  • Corbion NV
  • Zeus Industrial Products Inc.
  • Unitika Ltd.
  • Danimer Scientific
  • Synbra Technology
  • KLS Martin Group
  • Durect Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13570

Bioresorbable medical materials are substances specifically engineered to be absorbed or broken down by the body over time. These materials find applications in various medical scenarios, including surgical implants and tissue engineering scaffolds. They offer several advantages compared to permanent implants, as they eliminate the need for surgical removal once they have fulfilled their intended function.

The primary types of bioresorbable medical materials include polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL), and polylactic-co-glycolic acid (PLGA). Polylactic acid (PLA) is a biodegradable and bioresorbable polymer derived from renewable sources such as corn starch or sugarcane. PLA is commonly utilized in the production of bioresorbable medical materials, such as sutures, screws, and bone fixation devices. These materials serve diverse applications, including drug delivery and orthopedics, and are utilized by various end-users such as hospitals, clinics, ambulatory surgical centers, and research institutes.

The bioresorbable medical material research report is one of a series of new reports from The Business Research Company that provides bioresorbable medical material market statistics, including the bioresorbable medical material industry's global market size, regional shares, competitors with a bioresorbable medical material market share, detailed bioresorbable medical material market segments, market trends and opportunities, and any further data you may need to thrive in the bioresorbable medical material industry. This bioresorbable medical material market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioresorbable medical material market size has grown rapidly in recent years. It will grow from $1.4 billion in 2023 to $1.55 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth observed during the historical period can be attributed to several factors, including the limitations of traditional non-resorbable materials, advancements in polymer science leading to the development of bioresorbable materials, a surge in cardiovascular interventions utilizing these materials, the growth of the aging population, and the expansion of minimally invasive surgical procedures. These factors collectively contributed to the increased adoption of bioresorbable medical materials as a viable and advantageous alternative in various medical applications.

The bioresorbable medical material market size is expected to see strong growth in the next few years. It will grow to $2.24 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The anticipated growth in the forecast period can be attributed to several key factors, including the increasing demand for bioresorbable scaffolds, widespread adoption of bioresorbable materials across various medical applications, a rise in cardiovascular and orthopedic procedures utilizing these materials, a growing focus on patient comfort and faster recovery, and expanding applications in tissue engineering. Major trends expected in the forecast period include the customization of bioresorbable materials to suit specific medical applications, the integration of bioresorbable materials in drug delivery systems, the growth of 3D printing in the manufacturing of bioresorbable medical devices, the development of combination products featuring bioresorbable elements, and a heightened emphasis on sustainable and environmentally friendly medical materials. These trends signify the ongoing evolution of bioresorbable medical materials to meet diverse medical needs while aligning with the broader trends of customization, technological advancements, and sustainability in the healthcare industry.

The surge in surgical procedures is anticipated to significantly boost the bioresorbable medical material market's expansion. Surgical interventions involve incisions and specialized tools to treat diseases within the body. Bioresorbable polymers find extensive usage in molded medical equipment, notably in neurology, orthopedics, and cosmetic surgery. These materials are instrumental in producing items such as sutures, anchors, and screws. As an illustration, in 2022, as per the British Heart Foundation's report, the UK witnessed an increase in transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) surgeries, rising from 5,676 in 2019/20 to 6,328 in 2020/21. Hence, the escalating number of surgeries acts as a driving force for the bioresorbable medical material market.

The burgeoning aging population is poised to drive the growth of the bioresorbable medical material market significantly. An aging population signifies a demographic shift marked by a higher percentage of individuals aged 65 and above within a society. The increased demand for medical interventions among the elderly, coupled with a preference for advanced bioresorbable solutions that alleviate the necessity for subsequent surgeries to remove implants, fuels the expansion of the bioresorbable medical materials market. For instance, in 2022, according to visual capitalist, a Canadian company specializing in visual content on contemporary trends, the global population aged 65+ years totaled 771 million, accounting for nearly 10% of the world's populace. Therefore, the growing aging demographic is a key driver behind the growth of the bioresorbable medical material market.

The emergence of innovative biomaterials stands out as a prominent trend gaining traction within the bioresorbable medical material market. Key industry players are placing emphasis on the development of pioneering biomaterials specifically designed for 3D printing applications, aiming to fortify their market standing. An exemplary instance involves Evonik Industries AG, a German-based specialty chemicals company renowned for its expertise in bioresorbable materials. In June 2021, Evonik introduced a novel 3D-printable PEEK biomaterial named VESTAKEEP Care M40 3DF, catering to medical technology. This polyether ether ketone filament enables body contact for up to 30 days and is compatible with prevalent extrusion-based 3D printing technologies such as fused filament fabrication (FFF) or fused deposition modeling (FDM). This product launch marks Evonik's venture into broadening treatment options for patients through additive manufacturing techniques.

Prominent enterprises operating within the bioresorbable medical material sector are actively engaging in strategic alliances to fortify their market positions. Strategic collaborations empower these companies to unite with other firms possessing specialized expertise, enabling the transformation of conceptual ideas into tangible solutions. For instance, in December 2021, Boston Micro Fabrication (BMF), a pioneering US-based entity specializing in microscale 3D printing systems, formed a strategic partnership with 4D Biomaterials, a UK-based company focused on 3D printing materials. This collaboration aimed to utilize 4D Biomaterials' 4Degra bioresorbable materials in the micro-scale printing domain, achieving a significant milestone in printing bioresorbable materials using micro 3D printing technology. This innovation is poised to revolutionize the manufacturing landscape for implantable medical devices, showcasing the potential to address design intricacies and biocompatibility concerns encountered by medical device manufacturers. The amalgamation of BMF's innovative projection micro stereolithography (PµSL) approach with 4D Biomaterials' 4Degra resin inks signifies a breakthrough that holds promise in enhancing opportunities for implantable devices, ultimately advancing patient care standards.

In July 2021, BD (Becton, Dickinson, and Company), a leading US-based medical technology company, successfully acquired Tepha Inc. for an undisclosed amount. This strategic acquisition is aimed at accelerating the expansion of BD's surgical mesh portfolio and positioning the company to explore potential new markets in soft tissue repair, reconstruction, and regeneration. Tepha Inc., based in the United States, is recognized for its expertise in producing medical devices and bioresorbable scaffolds designed for applications in soft tissue repair. The acquisition underscores BD's commitment to advancing its capabilities and offerings in the field of medical technology, particularly in the rapidly evolving segment of bioresorbable materials for surgical applications.

Major companies operating in the bioresorbable medical material market report are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., COFCO Biotechnology Co. Ltd., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., Shenzhen eSUN Industrial Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

North America was the largest region in the bioresorbable medical material market in 2023. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioresorbable medical material market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioresorbable medical materials market consists of sales of chitosan, collagen, and calcium phosphates. Values in this market are 'factory gat' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioresorbable Medical Material Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioresorbable medical material market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioresorbable medical material ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioresorbable medical material market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Polylactic Acid (PLA); Polyglycolic Acid (PGA); Polysaccharides; Polycaprolactone (PCL); Poly Lactic-Co-Glycolic Acid (PLGA)
  • 2) By Application: Drug Delivery; Orthopedics; Other Applications
  • 3) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Research Institutes; Other End-Users
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic PLC; Kureha Corporation; Evonik Industries AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioresorbable Medical Material Market Characteristics

3. Bioresorbable Medical Material Market Trends And Strategies

4. Bioresorbable Medical Material Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Bioresorbable Medical Material Market Size and Growth

  • 5.1. Global Bioresorbable Medical Material Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Bioresorbable Medical Material Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Bioresorbable Medical Material Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bioresorbable Medical Material Market Segmentation

  • 6.1. Global Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)
  • Polysaccharides
  • Polycaprolactone (PCL)
  • Poly Lactic-Co-Glycolic Acid (PLGA)
  • 6.2. Global Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Delivery
  • Orthopedics
  • Other Applications
  • 6.3. Global Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Other End Users

7. Bioresorbable Medical Material Market Regional And Country Analysis

  • 7.1. Global Bioresorbable Medical Material Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Bioresorbable Medical Material Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bioresorbable Medical Material Market

  • 8.1. Asia-Pacific Bioresorbable Medical Material Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bioresorbable Medical Material Market

  • 9.1. China Bioresorbable Medical Material Market Overview
  • 9.2. China Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bioresorbable Medical Material Market

  • 10.1. India Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bioresorbable Medical Material Market

  • 11.1. Japan Bioresorbable Medical Material Market Overview
  • 11.2. Japan Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bioresorbable Medical Material Market

  • 12.1. Australia Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bioresorbable Medical Material Market

  • 13.1. Indonesia Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bioresorbable Medical Material Market

  • 14.1. South Korea Bioresorbable Medical Material Market Overview
  • 14.2. South Korea Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bioresorbable Medical Material Market

  • 15.1. Western Europe Bioresorbable Medical Material Market Overview
  • 15.2. Western Europe Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bioresorbable Medical Material Market

  • 16.1. UK Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bioresorbable Medical Material Market

  • 17.1. Germany Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bioresorbable Medical Material Market

  • 18.1. France Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bioresorbable Medical Material Market

  • 19.1. Italy Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bioresorbable Medical Material Market

  • 20.1. Spain Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bioresorbable Medical Material Market

  • 21.1. Eastern Europe Bioresorbable Medical Material Market Overview
  • 21.2. Eastern Europe Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bioresorbable Medical Material Market

  • 22.1. Russia Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bioresorbable Medical Material Market

  • 23.1. North America Bioresorbable Medical Material Market Overview
  • 23.2. North America Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bioresorbable Medical Material Market

  • 24.1. USA Bioresorbable Medical Material Market Overview
  • 24.2. USA Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bioresorbable Medical Material Market

  • 25.1. Canada Bioresorbable Medical Material Market Overview
  • 25.2. Canada Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bioresorbable Medical Material Market

  • 26.1. South America Bioresorbable Medical Material Market Overview
  • 26.2. South America Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bioresorbable Medical Material Market

  • 27.1. Brazil Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bioresorbable Medical Material Market

  • 28.1. Middle East Bioresorbable Medical Material Market Overview
  • 28.2. Middle East Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bioresorbable Medical Material Market

  • 29.1. Africa Bioresorbable Medical Material Market Overview
  • 29.2. Africa Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bioresorbable Medical Material Market Competitive Landscape And Company Profiles

  • 30.1. Bioresorbable Medical Material Market Competitive Landscape
  • 30.2. Bioresorbable Medical Material Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic PLC
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Kureha Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Evonik Industries AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Bioresorbable Medical Material Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. Toray Industries Inc.
  • 31.3. Mitsui Chemicals Inc.
  • 31.4. Arkema S.A.
  • 31.5. Royal DSM N.V.
  • 31.6. Zimmer Biomet Holdings Inc.
  • 31.7. COFCO Biotechnology Co. Ltd.
  • 31.8. Ashland Global Holdings Inc.
  • 31.9. Corbion N.V.
  • 31.10. Zeus Industrial Products Inc.
  • 31.11. Unitika Ltd.
  • 31.12. Danimer Scientific
  • 31.13. Synbra Technology
  • 31.14. KLS Martin Group
  • 31.15. Durect Corporation

32. Global Bioresorbable Medical Material Market Competitive Benchmarking

33. Global Bioresorbable Medical Material Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bioresorbable Medical Material Market

35. Bioresorbable Medical Material Market Future Outlook and Potential Analysis

  • 35.1 Bioresorbable Medical Material Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Bioresorbable Medical Material Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Bioresorbable Medical Material Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer